Braun Bostich & Associates Inc. Novartis Ag Transaction History
Braun Bostich & Associates Inc.
- $145 Million
- Q3 2025
A detailed history of Braun Bostich & Associates Inc. transactions in Novartis Ag stock. As of the latest transaction made, Braun Bostich & Associates Inc. holds 2,127 shares of NVS stock, worth $279,806. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,127
Previous 2,284
6.87%
Holding current value
$279,806
Previous $276,000
1.45%
% of portfolio
0.19%
Previous 0.2%
Shares
17 transactions
Others Institutions Holding NVS
# of Institutions
1,605Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...